logo
  • SELECT LICENSE :

  • US $4,299.00
  • US $8,599.00

Softgel Capsule Market, By Type (Gelatin Type, Non-Animal Type), By Application (Supplement, Vitamins, and Nutrition) opportunities and forecast 2020-2027

  • DLR2187
  • 19 September, 2020
  • Pharma & Healthcare
  • Pages: 120
  • Global
Market Overview

Softgel capsules are derived using gelatin as major raw material. Investments by the manufacturers in R&D activities and technological advancements have led to development and usage of the other sources for manufacturing these softgel capsules that are vegetarian in nature, and provide seamless manufacturing procedures. The health-conscious consumers market is seeking the natural, 'green' products is thriving. Over 50 percent of the consumers are currently willing to pay the premium price for natural product, and closely half are willing to pay more for the organic products, this is anticipated to drive growth of vegetarian softgel capsules (starch, HPMC, pullulan softgel capsules) segment.

Rising concerns among consumers and the healthcare spending have led to demand for health supplements, and prescribed medication globally. People are becoming conscious about the body deficiencies, and choosing for nutritional and vitamin supplements that are confined in oral dosage format, and are easy to swallow and the nutrients get well-absorbed in body. Thus, advent of the softgel capsules plays major role among the infants and children and the old people, as they face risk of not being capable to swallow tablet properly.

Segment Overview

Augmented consumption of the capsuled nutrition, vitamin, and supplement dosage to support growth of global softgel capsule market over the forecast period. Furthermore, sports nutrition is no longer taken by the weightlifters and professional athletes only. Global events, gym-goers, marathons, and game events have together thrown sports into spotlight, and rising interest in body image and fitness has made brands shift themselves towards providing products for healthy lifestyle. The growing interest among the consumers towards health awareness is likely to outweigh professional athletes. Thus, sellers are keeping more space for the sports nutrition products. This gives the sport supplement manufacturers opportunity to market the sports nutrition products to varied and vast consumer base in oral dosage format globally.

Regional Overview

North America is presently the largest market for the softgel capsule and is expected to retain its market position over 2026. The market in the North America surpassed a significant valuation in 2019. Existence of vast pharmaceutical sector and massive pool of the health-conscious consumers can be accredited to growth of market in North America. A sharp rise in the sales of the softgel capsules in APAC with China demonstrating the largest share. Augmented healthcare expenditure and the rapid expansion of pharmaceutical sector in the region has opened new opportunities for the market players operating in the region.

Competitor overview

Players in the softgel capsules market are providing oral bioavailability, content uniformity, and liquid as well as semi-solid preparations of medications by introducing the high-quality softgel capsules. Increasing popularity of the softgel format of the medication is supplementary encouraging manufacturers in the softgel capsules market to invest in the advanced developed technologies to introduce high-quality softgel capsules.

Key Players
  1. Catalent
  2. NBTY
  3. Procaps
  4. Aenova
  5. Patheon (now Thermo Fisher Scientific)
  6. IVC
  7. Captek
  8. Strides Shasun
  9. EuroCaps
  10. Lonza (Capsugel)
  11. Soft Gel Technologies
  12. Sirio Pharma
  13. Baihe Biotech
  14. Amway
  15. Ziguang Group
  16. Shineway
  17. By-Health
  18. Yuwang Group
  19. Donghai Pharm
  20. Guangdong Yichao

Market Segmentation

By Type
  • Gelatin
  • Noon-Animal Type
By Application
  • Supplements
  • Nutrition
  • Vitamins
By Geography
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • Rest of LAMEA


1 Report Prologue 13

    2 Market Introduction 16

    • 2.1 Scope of Study 17
    • 2.2 Research Objective 17
    • 2.3 List of Assumptions 17
    • 2.4 Market Structure 18

    3 Research Methodology 19

    • 3.1 Research Process 20
    • 3.2 Primary Research 21
    • 3.3 Secondary Research 22
    • 3.4 Market Size Estimation 23
    • 3.5 Forecast Model 23

    4 Market Dynamics 24

    • 4.1 Introduction 25
    • 4.2 Drivers 26
      • 4.2.1 Increasing investments by major market players in capsule manufacturing plants 26
      • 4.2.2 Rising applications of softgel capsules in nutraceutical industries 26
      • 4.2.3 Growth of the pharmaceutical industry provides opportunities for the softgel capsules market to grow worldwide 26
    • 4.3 Restraints 27
      • 4.3.1 High cost of vegetarian capsules 27
      • 4.3.2 Fluctuating prices of raw materials 27
      • 4.3.3 Rising demand for kosher- and halal-certified hard gelatin capsules 27
    • 4.4 Opportunities 28
      • 4.4.1 Non-gelatin softgel capsules 28
    • 4.5 Technology Trends & Assessment 28
      • 4.5.1 ‘Smart capsule' is a potential new drug-delivery vehicle 28
      • 4.5.2 Hydroxypropyl methylcellulose capsules (HPMC) 28
    • 4.6 Macroeconomic indicators 29

    5 Market Factor Analysis 30

    • 5.1 Value Chain Analysis 31
      • 5.1.1 R&D and Designing 31
      • 5.1.2 Manufacturing 31
      • 5.1.3 Distribution & Sales 32
      • 5.1.4 Post-sales Review 32
    • 5.2 Porter’s Five Forces Model 32
      • 5.2.1 Bargaining Power of Suppliers 33
      • 5.2.2 Bargaining Power of Buyers 33
      • 5.2.3 Threat of New Entrants 33
      • 5.2.4 Threat of Substitutes 33
      • 5.2.5 Intensity of Rivalry 33
    • 5.3 Investment Opportunities 34
    • 5.4 Pricing Analysis 34

    6 Global Softgel Capsule Market, By Type 35

    • 6.1 Introduction 36
      • 6.1.1 Gelatin type 36
      • 6.1.2 Non-animal type 36
      • 6.1.3 Gelatin Capsule 37
      • 6.1.4 Non- animal Capsule 38

    7 Global Softgel Capsule Market, By Application 39

    • 7.1 Introduction 40
      • 7.1.1 Vitamins 40
      • 7.1.2 Supplement 40
      • 7.1.3 Nutrition 40
      • 7.1.4 Vitamins 41
      • 7.1.5 Supplement 42
      • 7.1.6 Nutrition 43

    8 Global Softgel Capsule Market, By Region 44

    • 8.1 Introduction 45
    • 8.2 Americas 47
      • 8.2.1 North America 47
      • 8.2.2 Latin America 49
    • 8.3 Europe 51
    • 8.4 Asia – Pacific 53
      • 8.4.1 China 54
      • 8.4.2 Japan 55
      • 8.4.3 Rest of Asia-Pacific 57
    • 8.5 Rest of the World 59

    9 Competitive Landscape 61

    • 9.1 Competitive Scenario 62
      • 9.1.1 Introduction 62
    • 9.2 Company Market Share Analysis 63
      • 9.2.1 Introduction 63
    • 9.3 Key Developments 64

    10 Company Profile 65

    • 10.1 Catalent, Inc 66
      • 10.1.1 Company Overview 66
      • 10.1.2 Financial Overview 66
      • 10.1.3 Products Offering 67
      • 10.1.4 SWOT Analysis 67
      • 10.1.5 Key Developments 67
      • 10.1.6 Key strategy 67
    • 10.2 Patheon (Part of Thermo Fisher Scientific) 68
      • 10.2.1 Company Overview 68
      • 10.2.2 Financial Overview 68
      • 10.2.3 Products Offering 69
      • 10.2.4 SWOT Analysis 69
      • 10.2.5 Key Developments 69
      • 10.2.6 Key strategy 69
    • 10.3 Capsugel (A part of Lonza) 70
      • 10.3.1 Company Overview 70
      • 10.3.2 Company Overview 70
      • 10.3.3 Products Offering 71
      • 10.3.4 SWOT Analysis 71
      • 10.3.5 Key Developments 71
      • 10.3.6 Key strategy 71
    • 10.4 Captek Softgel International Inc. 72
      • 10.4.1 Company Overview 72
      • 10.4.2 Financial Overview 72
      • 10.4.3 Products Offering 72
      • 10.4.4 SWOT Analysis 72
      • 10.4.5 Key Developments 73
      • 10.4.6 Key Strategy 73
    • 10.5 EuroCaps Ltd. (Part of the DCC plc Group) 74
      • 10.5.1 Company Overview 74
      • 10.5.2 Financial Overview 74
      • 10.5.3 Products Offering 75
      • 10.5.4 SWOT Analysis 75
      • 10.5.5 Key Developments 75
      • 10.5.6 Key Strategy 75
    • 10.6 Amway 76
      • 10.6.1 Company Overview 76
      • 10.6.2 Financial Overview 76
      • 10.6.3 Products Offering 76
      • 10.6.4 SWOT Analysis 76
      • 10.6.5 Key Development 76
      • 10.6.6 Key Strategy 76
    • 10.7 Sirio Pharma Co. Ltd. 77
      • 10.7.1 Company Overview 77
      • 10.7.2 Financial Overview 77
      • 10.7.3 Products Offering 77
      • 10.7.4 SWOT Analysis 77
      • 10.7.5 Key Development 78
      • 10.7.6 Key Strategy 78
    • 10.8 Strides Pharma Science Limited 79
      • 10.8.1 Company Overview 79
      • 10.8.2 Financial Overview 79
      • 10.8.3 Products Offering 80
      • 10.8.4 SWOT Analysis 80
      • 10.8.5 Key Development 80
      • 10.8.6 Key Strategy 80
    • 10.9 International Vitamin Corporation 81
      • 10.9.1 Company Overview 81
      • 10.9.2 Financial Overview 81
      • 10.9.3 Products Offering 81
      • 10.9.4 SWOT Analysis 81
      • 10.9.5 Key Development 81
      • 10.9.6 Key Strategy 81
    • 10.10 Soft Gel Technologies, Inc. 82
      • 10.10.1 Company Overview 82
      • 10.10.2 Products Offering 82
      • 10.10.3 SWOT Analysis 83
      • 10.10.4 Key Development 83
      • 10.10.5 Key Strategy 83
    • 10.11 Weihai Baihe Biology Technological Co. Ltd. 84
      • 10.11.1 Company Overview 84
      • 10.11.2 Financial Overview 84
      • 10.11.3 Products Offering 84
      • 10.11.4 SWOT Analysis 86
      • 10.11.5 Key Development 86
      • 10.11.6 Key Strategy 86
    • 10.12 China Shineway Pharmaceutical Group Limited 87
      • 10.12.1 Company Overview 87
      • 10.12.2 Financial Overview 87
      • 10.12.3 Products Offering 88
      • 10.12.4 SWOT Analysis 88
      • 10.12.5 Key Development 88
      • 10.12.6 Key Strategy 88
    • 10.13 Yuwang Group 89
      • 10.13.1 Company Overview 89
      • 10.13.2 Financial Overview 89
      • 10.13.3 Products Offering 89
      • 10.13.4 SWOT Analysis 90
      • 10.13.5 Key Development 90
      • 10.13.6 Key Strategy 90
    • 10.14 Guangdong Yichao Biological Co. Ltd. 91
      • 10.14.1 Company Overview 91
      • 10.14.2 Financial Overview 91
      • 10.14.3 Products Offering 91
      • 10.14.4 SWOT Analysis 91
      • 10.14.5 Key Development 91
      • 10.14.6 Key Strategy 91

    11 Appendix 92

    • 11.1 Discussion Blue Print 93

    Report You Might be Interested